19 leading centres in structural biology distributed throughout Europe (Table 1 ). The project was coordinated from Oxford and organized into a series of workpackages to each of which various combinations of SPINE laboratories contributed. Eight workpackages covered technology development and implementation; the results from each are reviewed in turn in the first eight papers of this volume. These methodological results underpinned the biomedical target based workpackages which were the heart of the project. The structures and biological insights resulting from these workpackages are reviewed in this issue by Fogg et al. (for the pathogen target systems) and Banci et al. (for the human target systems). Finally, a strong training and networking component was built into the project via two further workpackages with the explicit aim of creating an expanding European resource of highly trained structural biologists and technicians to carry forward structural proteomics into the next decade (see Fig. 1) .
At a broader level SPINE has been a catalyst for the development of a distributed network of laboratories with HTP capability in many countries and we believe it has helped to establish a democracy in the use of new technologies (e.g. affordable nano-crystallization and expression screening robotics). With this emphasis on the development and dissemination of methodologies, the SPINE project perhaps most closely resembled teams such as the Joint Center for Structural Genomics (JCSG, http://www.jcsg.org) in the USA, which also emphasised collaborative technology development perhaps at the expense of sheer numbers of structures in the early stages. At the end of the three-year SPINE project the progress towards its overarching goals can begin to be assessed. The success of SPINE can be measured in terms of an increase in the ability of European structural biologists to enrich the PDB with biomedically relevant protein structures. In numerical terms, SPINE's achievements (Table 2) SPINE has also pushed forward the development of European standards in several areas of HTP methods, notably LIMS and the handling of frozen crystals (http://www. spineurope.org/page.php?page=protocol_vials). SPINE was driven by the notion of 'human health targets' rather than a bioinformatics based 'fold space'. By its policy of an open, decentralized network and focus on high value targets, SPINE tried to go beyond the potentially divisive dichotomy between the 'traditional' way of doing structural biology ('one postdoc/one project' with in-depth complementary functional investigations) and 'factory-style' structural genomics (multiple parallel projects, abandoning of failures, targets often of unknown function). We believe that modes of work akin to those of SPINE, whereby HTP techniques are exploited for high-value targets, are likely to become the norm for structural biology. Such approaches may be essential if the ability of X-ray crystallography to illuminate biology is to advance fully from isolated protein to the macromolecular complexes central to cell biology.
The SPINE statistics, showing a total of 308 structures solved, reflect novel structures only, the number including ligand-and metal ion-bound isoforms is more than 370.
preface Table 2 A summary of the structure tally of JCSG and SPINE. 
